ACAD ACADIA Pharmaceuticals Inc.
Healthcare$21.10-1.03%ClosedMarket Cap: $3.61B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$34.78
Target (Median)
$35.00
Target Range
$29.00 - $40.00
Upside from current price: 64.8%
Rating Distribution
4 Strong Buy12 Buy4 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Citigroup | maintain | Buy | Buy |
| 2026-03-25 | B of A Securities | upgrade | Buy | Neutral |
| 2026-03-04 | JP Morgan | maintain | Overweight | Overweight |
| 2026-02-26 | RBC Capital | maintain | Outperform | Outperform |
| 2026-02-26 | Stifel | maintain | Hold | Hold |
| 2026-02-26 | TD Cowen | maintain | Buy | Buy |
| 2026-02-26 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-02-23 | Mizuho | upgrade | Outperform | Neutral |
| 2026-02-06 | Oppenheimer | maintain | Perform | Perform |
| 2026-02-03 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.77 | $1.39B | 13 |
| Sun Dec 31 | $1.44 | $1.57B | 15 |
| Mon Dec 31 | $1.75 | $1.64B | 10 |
| Tue Dec 31 | $2.37 | $1.80B | 6 |